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Background: There are several mobile health (mHealth) apps in mobile app stores. These apps enter the business-to-customer
market with limited controls. Both, apps that users use autonomously and those designed to be recommended by practitioners
require an end-user validation to minimize the risk of using apps that are ineffective or harmful. Prior studies have reviewed the
most relevant aspects in a tool designed for assessing mHealth app quality, and different options have been developed for this
purpose. However, the psychometric properties of the mHealth quality measurement tools, that is, the validity and reliability of
the tools for their purpose, also need to be studied. The Consensus-based Standards for the Selection of Health Measurement
Instruments (COSMIN) initiative has developed tools for selecting the most suitable measurement instrument for health outcomes,
and one of the main fields of study was their psychometric properties.
Objective: This study aims to address and psychometrically analyze, following the COSMIN guideline, the quality of the tools
that are used to measure the quality of mHealth apps.
Methods: From February 1, 2019, to December 31, 2019, 2 reviewers searched PubMed and Embase databases, identifying
mHealth app quality measurement tools and all the validation studies associated with each of them. For inclusion, the studies had
to be meant to validate a tool designed to assess mHealth apps. Studies that used these tools for the assessment of mHealth apps
but did not include any psychometric validation were excluded. The measurement tools were analyzed according to the 10
psychometric properties described in the COSMIN guideline. The dimensions and items analyzed in each tool were also analyzed.
Results: The initial search showed 3372 articles. Only 10 finally met the inclusion criteria and were chosen for analysis in this
review, analyzing 8 measurement tools. Of these tools, 4 validated ≥5 psychometric properties defined in the COSMIN guideline.
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Although some of the tools only measure the usability dimension, other tools provide information such as engagement, esthetics,
or functionality. Furthermore, 2 measurement tools, Mobile App Rating Scale and mHealth Apps Usability Questionnaire, have
a user version, as well as a professional version.
Conclusions: The Health Information Technology Usability Evaluation Scale and the Measurement Scales for Perceived
Usefulness and Perceived Ease of Use were the most validated tools, but they were very focused on usability. The Mobile App
Rating Scale showed a moderate number of validated psychometric properties, measures a significant number of quality dimensions,
and has been validated in a large number of mHealth apps, and its use is widespread. It is suggested that the continuation of the
validation of this tool in other psychometric properties could provide an appropriate option for evaluating the quality of mHealth
apps.
(JMIR Mhealth Uhealth 2021;9(12):e15433) doi: 10.2196/15433
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Introduction
Background
Nowadays, in the age of digital content, people, regardless of
age group, have access to mobile and smart devices (eg, phones,
tablets, and smart televisions), or special devices with the
possibility of internet connection. In dedicated (iOS and
Android) app stores (Apple App Store and Google Play Store),
there are thousands of apps with a vast number of functions,
and this number is increasing every day. According to a new
report by Grand View Research, Inc [1], the mobile health
(mHealth) app market size is expected to reach US $149.3
billion by 2028 and is expected to register a compound annual
growth rate of 17.7% over the forecast period. In these app
catalogs, mHealth apps are a very important field, and there has
been a growing interest from users in the last few decades. Some
studies report that up to 34% of mobile phone owners have at
least one health app installed on their device [2]. The World
Health Organization [3] described the term mHealth as the use
of mobile wireless technologies for health, being a subset of
eHealth, which is described as the use of information and
communications technology in support of health and
health-related fields. The World Health Organization [3] also
highlighted the relevance of digital health interventions to
address health needs, remarking that they should always be used
as an aid and an improvement for health systems, not as a
substitute.
The variety of features in apps available on different platforms
or cross-platforms is wide. Therefore, many of the mHealth
apps are (1) simply a catalog of recommendations; some of
them work as a (2) follow-up tool, complementing an
intervention program, whereas other mHealth apps are (3)
connected to dedicated sensors to offer information about health
signals or health status.
Most of these mHealth apps enter the market with limited filters
or controls that usually do not consider aspects such as the
veracity of its content and their effectiveness as relevant [4].
According to a previous study, only a small percentage of
available apps in some health fields have referred to medical
professional involvement in their development or content [5].
Both, apps that users use autonomously and those that can be
directly recommended by clinicians to their patients require a
prior study that investigates their evidence to minimize the risk
of using the apps that do not work or that may even cause harm
[6,7]. The development of these studies and analyses have been
described in academic contexts, but its execution is not always
easy in commercial apps [5]. Some experts attribute this fact to
a much slower pace of academic research than that of app
development, which can result in long delays in the diffusion
of apps in commercial markets and among users [8]. Thus, many
of the apps are only rated by the general subjective perception
of users with vague rating tools, such as numerical or star-based
scores from 1 to 5.
Many attempts have been made to develop effective and
practical validation tools to measure the quality of mHealth
apps. The quality-based concept has been interpreted in different
ways according to each author and field, evaluating or resulting
in different components [9]. Some of the first attempts used
existing generic tools, such as the System Usability Scale (SUS)
[10], to measure the usability, that is, the ease of use, of systems.
This tool was developed in 1986 to allow a quick and basic
measurement of the usability of any system and is still used in
many studies despite being 30 years old. The increase in the
use of new technologies, such as smartphones and health apps,
brought the need to develop new types of mHealth apps with
specific measurement tools that adapt the existing ones.
Previous studies have reviewed which methods have been used
to assess the quality of mHealth apps [11,12], determining which
aspects could be the most relevant in a tool designed for this
purpose [2]. In general, quality evaluation methodologies can
be divided into 2 categories: (1) methodologies based on the
downloaded app content (using a predefined list of requirements
that the app should contain, assessing the inclusion of
evidence-based content, and assessing the usability of predefined
app functions) and (2) methodologies that are
content-independent and the app does not need to be downloaded
(using app market or website assessment tools, users’ reviews
and ratings, and other assessment methods such as the analysis
of the app description or a medical professional involvement
in the app) [11]. Similarly, a previous review suggested that the
essential contents to be evaluated can be grouped into 4
categories: (1) content analysis (coding and qualitatively
evaluating the app content); (2) usability testing (evaluating
whether the app works correctly and its ease of use); (3)
observational studies (that can be used to assess app use and
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satisfaction and to predict its usefulness in certain contexts);
and (4) efficacy testing (assessing whether the app achieves
meaningful effects in previously determined outcomes) [2].
Other areas of interest in this quality evaluation may include
exploring the technical functions of the app, the management
of security and privacy of user data, and how the developer will
use these or developer transparency [2]. Because the
measurement tools do not measure all the dimensions and
properties of an mHealth app, a prior analysis is necessary to
select the appropriate tool for each purpose.
In addition to the inclusion of the previously proposed aspects,
it is important to determine the validity of these instruments,
that is, the ability to properly assess what they intend to assess.
Therefore, it is relevant for any measurement tool to study its
psychometric properties. Psychometric properties are different
concepts related to the validity and reliability of the instruments,
each helping us to determine whether a tool adequately does
what it was designed to do according to essential aspects. The
development of psychometrics has provided the possibility of
knowing the existence of individual differences in the use of
measurement tools and their quantification [13,14]. In 2005,
the Consensus-based Standards for the Selection of Health
Measurement Instruments (COSMIN) started to develop
practical tools for selecting the most suitable measurement
instrument in research and clinical practice to improve the
selection of outcome measurement instruments for health
outcomes. One of the main fields of study was the psychometric
properties of the assessment tools. Psychometric analysis, using
a wide variety of terminology, has been a source of controversy
and confusion for decades. The progress of the COSMIN
initiative has improved this aspect through the development of
the COSMIN Taxonomy of Measurement Properties. This tool
aims to standardize the psychometric criteria necessary to
validate patient-reported outcome measures [15,16]. These
guidelines were not specifically designed for digital health.
However, it is necessary to bring the tools of psychometrics
closer to this field to evaluate the measurement instruments
used to choose mHealth apps in a clinical context. Therefore,
it is essential to integrate this analysis in the field of digital
health in their original format and possibly later in a more
specific version adapted for this field. In this context, a wide
analysis of mHealth assessment tools, following this guide,
seems to be an appropriate method for assessing their quality
and suitability, bringing scientific consensus closer to this field
of health.
Objective
The purpose of this systematic review is to address and
psychometrically analyze, following the COSMIN guideline,
the quality of the tools that are currently used to measure the
quality of mHealth apps.
Methods
This systematic review was conducted in accordance with the
PRISMA (Preferred Reporting Items for Systematic Reviews
and Meta-Analyses) guidelines [17].
Data Sources and Searches
PubMed and Embase databases were processed by 2 reviewers
(AE-E and AM-C) from February 2019 to December 31, 2019.
The following search term combinations were used in PubMed:
(mHealth OR mobileapp* OR healthtechnology) AND (scale
OR checklist OR score) AND app. The search was extended to
all fields. Embase was searched using the following search
string: (health/exp OR health) AND app AND (quality/exp OR
quality). Complementary searches were performed on the
reference lists of the reviews and included articles. The outcome
selection process was as follows: when a tool was identified,
the instrument was specifically searched in the database search
engines, to find all the validation studies associated with this
tool.
For inclusion, the studies had to be meant to validate a tool
(scale, score, index, or questionnaire) designed to evaluate the
quality of systems and used to assess mHealth apps.
Studies that included the application of these tools for the
evaluation of mHealth apps but that did not include any type of
psychometric validation were excluded. In addition, studies that
contained self-written questionnaires where authors focused on
measuring usability or content of apps without any validation
of their use were also excluded because of the lack of reliability.
Study Selection
The search results were screened by title and abstract by 2
independent authors (AE-E and AM-C). Whenever the
information contained in the title and abstract was insufficient,
the full text was examined to decide. Full texts of all potentially
eligible studies were independently screened by the same
reviewers to identify those that met the abovementioned
selection criteria. Disagreements were agreed upon by a third
reviewer (AIC-V). Finally, the measurement tools included in
the selected studies were identified and retrieved.
Data Extraction
Data from the selected studies were extracted by the same
independent reviewers using an extraction form. The extracted
information included the original language, cross-cultural
adaptations available, number of dimensions, number of items,
and the fulfillment of the 10 psychometric characteristics
described in COSMIN (internal consistency, reliability,
measurement error, content validity, structural validity,
hypotheses testing, cross-cultural validity, criterion validity,
responsiveness, and interpretability). Any discrepancies
identified were discussed and resolved by bringing in a third
reviewer (AIC-V) whenever a consensus could not be reached.
Quality Assessment: Psychometric Characteristics
(COSMIN Analysis)
The psychometric characteristics of each of the retrieved tools
were analyzed following the COSMIN guidelines [15] based
on the COSMIN Taxonomy of Measurement Properties to assess
their methodological quality. The COSMIN guideline also offers
updated values to consider psychometric properties as sufficient
[15]. The definitions provided by COSMIN for all psychometric
characteristics are presented in Table 1. We examined 10
psychometric characteristics. First, the content validity of each
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tool was assessed. According to COSMIN, content validity is
considered to be the most important measurement property
because it evaluates whether an outcome measurement
instrument is relevant, comprehensive, and comprehensible with
respect to the construct of interest and target population [15].
Second, the internal structure of the outcome measures was
evaluated using structural validity, internal consistency, and
cross-cultural validity. Third, the remaining measurement
properties were evaluated (reliability, measurement error,
criterion validity, hypotheses testing for construct validity, and
responsiveness). Finally, the interpretability and feasibility of
each measurement tool were evaluated.
Table 1. Consensus-based Standards for the Selection of Health Measurement Instruments definitions of domains, measurement properties, and aspects
of measurement properties [18].
DefinitionAspect of a measure-
ment property
Measurement propertyDomain
The degree to which the measurement is free from measurement errorN/AN/AaReliability
The extent to which scores for patients who have not changed are the
same for repeated measurement under several conditions: for example,
using different sets of items from the same HR-PROsb (internal consis-
tency) over time (test-retest), by different persons on the same occasion
(interrater), or by the same persons (ie, raters or responders) on different
occasions (intrarater)
Reliability (extended definition)
The degree of the interrelatedness among the itemsN/AInternal consistency
The proportion of the total variance in the measurements which is due
to truec differences between patients
N/AReliability
The systematic and random error of a patient’s score that is not attribut-
ed to true changes in the construct to be measured
N/AMeasurement error
The degree to which an HR-PRO instrument measures the construct it
purports to measure
Validity
The degree to which the content of an HR-PRO instrument is an ade-
quate reflection of the construct to be measured
Content validity
The degree to which (the items of) an HR-PRO instrument indeed looks
as though they are an adequate reflection of the construct to be measured
Face validity
The degree to which the scores of an HR-PRO instrument are consistent
with the hypotheses (for instance, with regard to internal relationships,
relationships to the scores of other instruments, or differences between
relevant groups) based on the assumption that the HR-PRO instrument
validly measures the construct to be measured
Construct validity
The degree to which the scores of an HR-PRO instrument are an ade-
quate reflection of the dimensionality of the construct to be measured
Structural validity
Idem construct validityHypotheses testing
The degree to which the performance of the items on a translated or
culturally adapted HR-PRO instrument are an adequate reflection of
the performance of the items of the original version of the HR-PRO
instrument
Cross-cultural validity
The degree to which the scores of an HR-PRO instrument are an ade-
quate reflection of a gold standard
N/ACriterion validity
The ability of an HR-PRO instrument to detect change over time in the
construct to be measured
Responsiveness
Idem responsivenessN/AResponsiveness
Interpretability is the degree to which one can assign qualitative
meaning, that is, clinical or commonly understood connotations, to an
instrument’s quantitative scores or change in scores
N/AN/AInterpretabilityd
aN/A: not applicable.
bHR-PRO: health-related patient-reported outcome.
cThe word true must be seen in the context of the classical test theory, which states that any observation is composed of 2 components: a true score and
an error associated with the observation. True is the average score that would be obtained if the scale were given an infinite number of times. It refers
only to the consistency of the score and not to its accuracy.
dInterpretability is not considered a measurement property but is an important characteristic of a measurement instrument.
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The information obtained from the validation of the
psychometric criteria was used in 2 ways. First, the number of
properties described in the COSMIN guideline that were
validated was quantified. Second, the meaning of the values
obtained for each property was analyzed.
Measured Dimensions
The number and content of the measured dimensions were
identified to facilitate the characterization of each measurement




The literature research identified 3372 articles, of which 2831
remained after deleting duplicates. From these, 65 studies were
selected as potentially eligible after reading the title and abstract
(full texts of the studies were retrieved in the case of doubt).
We excluded 20 studies because they did not include any
measurement tool, and 13 studies were excluded because of the
use of nonvalidated self-written questionnaires. After analyzing
the psychometric characteristics, 22 studies were excluded
because of the lack of validation of any of the psychometric
properties recommended by the COSMIN guideline. Therefore,
only 10 studies were finally included in the review (Figure 1),
including the development process or analysis of 8 measurement
tools, with some of these different versions of the same original
tool. Therefore, 2 tools (Mobile App Rating Scale [MARS] and
mHealth Apps Usability Questionnaire [MAUQ]) have different
versions for users and professionals. In addition, the MAUQ
provides different versions for interactive or stand-alone
mHealth apps.
Figure 1. Flowchart of the selection process. COSMIN: Consensus-based Standards for the Selection of Health Measurement Instruments.
Measurement Tools
The oldest scale identified was the SUS, which was developed
in 1986, whereas the newest was the MAUQ, which was
developed in 2016. In total, 8 tools were identified, some of
which were different versions of the same original tool.
Usability
As described in the Introduction section, the SUS tool was
initially developed to evaluate the usability of engineering and
electronic office systems. Nowadays, it is used to evaluate many
products and services, such as software, webpages, or mobile
apps. It focuses on measuring usability using a Likert scale of
10 elements [10]. It has been adapted to multiple languages,
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such as Portuguese, Spanish, French, German, Persian, and
Malay, and it is considered a highly reliable tool [19-22].
Similarly, 3 other tools included were specifically designed to
assess usability [23-25]. First, the tool Measurement Scales for
Perceived Usefulness and Perceived Ease of Use was developed
in 1989 to measure the usability of computer systems [23]. As
its name suggests, this tool incorporates 2 scales to evaluate the
perception of 2 aspects of usability: usefulness and ease of use.
Second, the Health Information Technology Usability Evaluation
Scale (Health-ITUES) questionnaire was one of the first
questionnaires to focus specifically on health areas [24]. Initial
attempts to develop and value Health-ITUES were conducted
using a web-based communication system that supported nurse
staffing and scheduling [26]. However, its use in an mHealth
app was not validated until a few years ago [27]. Finally, the
MAUQ questionnaire exclusively focuses on the usability
aspects of apps [25]. This questionnaire provides 4 versions,
depending on whether it is used by a health professional or by
a patient and whether it is intended to analyze an interactive or
stand-alone app (interactive app for patients, interactive app for
health care providers, stand-alone app for patients, and
stand-alone app for health care providers). However, only the
patient’s versions have been validated and are therefore included
in the analysis of this review, as shown in Table 2.
Table 2. Main characteristics of the mobile health apps quality measurement tools included in this review.
Number of
items
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iSYScore, developed in 2015, was initially designed to measure
the reliability and overall quality of mHealth apps, not only
their usability [28]. It was validated according to 3 main aspects:
popularity and interest, trust and quality, and usefulness [28].
Another important tool was the MARS developed in 2015 [29].
This scale has been adapted to Spanish and Italian languages
[30]. It is worth noting that, in addition to its original version,
this tool has a specific user version—user version of MARS
(uMARS)—developed in 2016 [31]. Both the MARS versions
(user and professional versions) focus on measuring other
components of the quality of mHealth apps and not just usability,
and they are widely used methods for measuring the quality of
mHealth apps in different contexts [32-39]. The number of items
and the different dimensions assessed by each mHealth
measurement tool, as well as the main characteristics, are listed
in Table 2.
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Quality Assessment: Psychometric Characteristics
(COSMIN Analysis)
The main characteristics and the results of the quality analysis
according to the psychometric properties of the measurement
tools (COSMIN analysis) are summarized in Multimedia
Appendix 1. Most of the studies did not assess or report all the
properties recommended by COSMIN. Therefore, the
information reflected in this review refers to the values of the
properties reported in the original studies consulted.
Discussion
Principal Findings
The aim of this study is to review the literature and collect and
analyze the tools used to assess the quality of mHealth apps.
As described earlier, an objective criterion (analysis of
psychometric characteristics through the COSMIN guideline)
was used along with a subjective criterion (assessment of the
adequacy of the number of dimensions and items evaluated by
the tools). The main finding of this review was the generalized
lack of validation of the psychometric characteristics of the
available tools, including those most commonly used. In
addition, there is no robust set of outcome measures for
understanding the different dimensions of mHealth apps. For
overall quality, the MARS scale seems to be a potentially valid
tool to establish a standardized use of it.
Validation of Psychometric Properties and Dimensions
Included: 2 Characteristics to Consider When
Choosing an Appropriate Tool
Usability Measurement
Regarding psychometric validation, 5 of the mHealth
measurement tools included in this review met 4 or more of the
properties recommended in the COSMIN guideline. The most
validated tools are the Measurement Scales for Perceived
Usefulness and Perceived Ease of Use and the Health-ITUES,
with validation of 6 out of the 10 psychometric properties, and
the SUS and the 2 versions of the MAUQ, with the validation
of 4 properties each. However, these tools mainly focus on
usability. Although usability is a critical aspect of an app that
is expected to be used regularly, quality assessment cannot focus
solely on this feature. This is worth highlighting because
depending on whether the professional intends to assess only
this specific dimension or requires further examination of
mHealth apps, the choice of measurement tool based solely on
the amount of validated psychometric properties may not be
sufficient. The Measurement Scales for Perceived Usefulness
and Perceived Ease of Use and the SUS are frequently used for
evaluating mHealth apps; however, they are not mobile-specific.
In contrast, the Health-ITUES and the MAUQ were explicitly
designed for smartphones, as they allow one to evaluate the
specific properties of this type of technology. The main
limitation of Health-ITUES is that a unique mHealth app
developed for community-dwelling adults living with HIV was
used to validate the psychometric characteristics.
General Assessment
Considering the variety of dimensions evaluated, both MARS
scales (professional and user versions) seem to be the tools that
allow the most detailed measurement, assessing 5 aspects of
the mHealth apps: engagement, functionality, esthetics,
information quality, and subjective app quality. The evaluation
of these additional characteristics of the apps allows for an
in-depth analysis. Similarly, the MARS scale contains items
related to the theoretical background, target population, or
technical aspects of security or privacy of user data. However,
these are not considered in the final score of the measurement
instrument. Both user and professional versions have validated
3 essential psychometric properties with adequate results using
around 60 mental health apps (content validity, evaluated by
an expert panel to select the questionnaire items; internal
consistency, Cronbach α=.90; and reliability, intraclass
correlation=0.79 and 0.70 for professional and user versions,
respectively). One of the strengths of this tool is the availability
of a specific version for users (uMARS) with validation of the
same psychometric characteristics (and with similar results) as
the standard version. In addition, the MARS scale has been
cross-culturally adapted and validated for different languages
and is currently being adapted to other languages. There is
abundant literature on the use of MARS for the evaluation of
several mHealth apps, making it one of the most studied tools
for assessing the quality of this kind of app.
The iSYScore tool is another method for measuring the overall
quality of mHealth apps [28]. This tool has 2 significant
disadvantages: it has insufficient validation (only content
validity by an expert panel) and is only available in the Spanish
language, so its use is severely limited.
Availability of Different Versions of the Tools: Are
They All Equally Studied?
Overview
Most of these tools focus on professional use. They seek to
measure the usability or the overall quality of mHealth apps in
an expert way [10,23,24,28]. However, allowing users of a
specific population to evaluate the quality of apps designed for
their use can allow one to analyze quality from another point
of view, by dividing the beliefs and expectations of professionals
and users. This requires the development of tools specifically
designed for users or, at least, validated versions. Only 2 of the
tools included in this review have a user version. The MARS
[29] uses uMARS as the user version [31]. The MAUQ has 2
versions: the stand-alone mHealth app for patients and the
interactive mHealth app for patients [25]. Therefore, one of the
main strengths of the MAUQ tool is the availability of 4 versions
of the questionnaire: interactive apps for patients, interactive
apps for providers, stand-alone apps for patients, and stand-alone
apps for providers. This fact allows greater versatility in the use
of the questionnaire, which is specific for each type of user and
app. However, only the 2 user versions have been tested and
validated using 2 health apps, so the validity and reliability of
the professional versions should still be studied.
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Lack of Reliability of Self-created Questionnaires
The objective of this review was to use psychometrically
validated measurement tools to assess mHealth apps. However,
in the scientific literature, there are mainly 2 options used by
authors in studies for this evaluation of mHealth apps. First, a
large number of authors choose to use self-created
questionnaires explicitly designed to evaluate the characteristics
of their specific apps. Because it can be personalized, this option
allows greater flexibility than other generic tools. However,
most of these tools are used in studies that do not focus on their
validation by recruiting small samples of participants that do
not allow a reliable analysis of the psychometric characteristics.
Consequently, although personalized questionnaires are
frequently used to determine the usability and quality of app
contents, their lack of validation and the lack of knowledge
about their reliability raise questions about their suitability for
use. Therefore, this type of tool was not included in this review.
Second, many authors choose to use previously validated tools
to maximize the reliability of the results obtained, despite the
possible loss of personalization derived from the use of generic
tools. Traditionally, there has been widespread use of tools
designed for the technological environment in health, such as
the SUS scale, which is still used today. However, the use of
tools not specifically designed for mobile environments limits
the analysis of specific characteristics of this type of technology.
For this reason, it is essential to standardize the use of validated
measurement tools designed explicitly for mobiles.
Developer Transparency and Data Privacy and Security
This review shows a lack of evaluation of relevant aspects of
mHealth apps, such as developer transparency and policies
regarding user data privacy and security [1]. Although some
tools such as MARS incorporate items with some of these
aspects, the fact that these are not included in the final scores
of the available tools demonstrates the need to focus on this
point.
Strengths and Limitations
This is the first review to analyze the psychometric
characteristics of the assessment tools of mHealth apps adhering
to the COSMIN criteria. The main weakness is the difficulty in
performing an optimal search and establishing adequate selection
criteria because of the great heterogeneity in the tools and
studies available in the literature. Another weakness is the
possible risk of bias due to the possibility of losing a tool
published in unreviewed databases. The implemented systematic
methodology minimized biases derived from this situation.
Future studies should focus on creating and validating new tools
or improving the validation of the most commonly used tools.
Conclusions
In conclusion, although there is growing evidence about the use
of tools to assess the quality and content of mHealth apps, the
availability of specific, highly validated tools for mobile apps
is still an unexplored topic in the market. There is no robust
scorecard to understand the different dimensions of mHealth
apps. The COSMIN guideline allows clinicians and scientific
consensus to be brought closer to the field of digital health.
According to the psychometric properties, the Health-ITUES
scale and the Measurement Scales for Perceived Usefulness and
Perceived Ease of Use were the most validated tools. However,
the validation is specific to a single app from a field, and its
design is focused on evaluating its usability aspects. The MARS
tool obtained adequate outcomes in a moderate number of
psychometric characteristics, and it has been validated in a large
number of mHealth apps. Its current use is widespread and
evaluates different aspects of the app quality, as well as its
usability.
This review suggests that the continuation of the validation of
this tool in other psychometric properties might provide an
appropriate option for evaluating the quality of mHealth apps
that is requested by the market in the long term to quickly
identify relevant apps.
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